Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A, biofeedback electromyography, and physical therapy for post-Bell's palsy facial synkinesis
PACTR201811856336735Not yet recruiting
- Sponsor
- Cairo University
- Start
- Nov 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of botulinum toxin type A in Bell's palsy and Facial synkinesis, sponsored by Cairo University. Primary endpoint: The Sunnybrook Facial Grading System. Planned start Nov 2018; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
Bell's palsyFacial synkinesis
Beyond the preview
Go deeper on PACTR201811856336735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201811856336735.